niraparib / abiraterone acetate
| Product Overview | |
| Generic Name | niraparib / abiraterone acetate |
| Brand Name(s) | Akeega® |
| Form | Film-coated tablets; oral use |
| Strength | 50 mg/500 mg; 100 mg/500 mg |
| Therapeutic Class | Antineoplastic combination; PARP inhibitor + androgen biosynthesis inhibitor |
| ATC Code | L01XK52 |
| Manufacturing & Regulatory | |
| GMP Compliance | WHO-GMP, EU-GMP |
| COFEPRIS | Under Registration (2025) |
| Logistics & Export | |
| MOQ | 10 Units |
| Shelf Life | 24 Months |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
